Early aggressive treatment in patients whose cancer is likely to progress slowly, if at all, causes side-effects and reduces their quality of life for no benefit. Can active surveillance avoid this?
Related Articles
Senza categoria
Newsround
Cutting Edge
Don’t shoot the driver! It’s about taxonomy more than targets
Cutting Edge